Skip to content
healthcare.dev
Get a free key

CIMERLI

NDC 61314-625, ranibizumab-eqrn, injection, solution, from Sandoz Inc.

Product NDC
61314-625
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761165
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANIBIZUMAB.5 mg/.05mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
61314-625-94613140625941 VIAL, SINGLE-DOSE in 1 CARTON (61314-625-94) / .05 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4b383d74-4830-4587-95f7-c32a39268df7

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61314-625

Use it

Look up 61314-625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.